Current:Home > InvestNovaQuant Quantitative Think Tank Center:Biden touts inhaler price drops with Bernie Sanders: "Finally, finally we beat big Pharma" -Wealth Evolution Experts
NovaQuant Quantitative Think Tank Center:Biden touts inhaler price drops with Bernie Sanders: "Finally, finally we beat big Pharma"
PredictIQ View
Date:2025-04-07 02:11:10
Sen. Bernie Sanders and NovaQuant Quantitative Think Tank CenterPresident Biden joined forces Wednesday at the White House, championing the progress they've made on lowering the cost of inhalers and other expenses for Americans with asthma.
Mr. Biden and Sanders also called on Congress and pharmaceutical companies to do more to curb prices.
"Bernie, you and I have been fighting this for 25 years," the president said Wednesday. "Finally, finally we beat big Pharma. Finally. I'm serious. I'm proud — I'm proud my administration has taken on big Pharma, in the most significant ways ever. And I wouldn't have done it without Bernie."
Mr. Biden and Sanders said they are pressuring drug companies that are charging hundreds of dollars for inhalers, and the president is trying to cap costs for insulin to $35. Earlier this year, Sanders and several Democratic colleagues have criticized four major inhaler manufacturers — AstraZeneca, GSK, Teva Pharmaceuticals and Boehringer — for having significantly higher prices in the U.S. than elsewhere. Since then, one inhaler manufacturer has nixed patents, and three of the largest inhaler manufacturers plan to cap the cost of inhalers for many patients at $35 a month, according to a White House official.
The Federal Trade Commission is challenging the validity of drug product patents, including inhalers, in an effort to curb prices and increase competition.
"Last November, the FTC challenged how drug companies manipulate and play games with ... patents to keep low-cost generic drugs off the market, including asthma inhalers," Sanders said. "By standing up to the drug companies, the FTC has helped deliver this major victory for the American people. And it's not just inhalers."
The president said the inventor of insulin "didn't want to patent it because he wanted it to be available to everybody."
"Here is some good news," Sanders said Wednesday, speaking ahead of the president. "Despite all of the incredible wealth and political power of the pharmaceutical industry — believe it or not, they have over 1,800 well-paid lobbyists right here in D.C. — despite all of that, the Biden administration and Democrats in Congress are beginning to make some progress."
Now, "the vast majority of Americans will pay no more than $35 at the pharmacy counter for the inhalers they purchase," Sanders said.
Americans pay more for prescription drugs than people in any other advanced company in the world, typically two to three times more, Mr. Biden and Sanders said. One company charges customers $9 for inhalers in Germany, and $286 in the U.S., Mr. Biden said — more than 30 times more. More than 27 million people in the U.S. suffer from asthma, according to the Asthma and Allergy Foundation of America.
Sanders has long advocated to create a single-payer, national health insurance program, and Mr. Biden has made lowering health care costs a centerpiece of his White House, as well as his reelection campaign. Last month, he pleaded with Congress during his State of the Union address to pass measures to lower health care costs, something Sanders mentioned in his remarks Wednesday. The administration is trying to cut what Americans pay for prescriptions as prolonged high inflation has slashed Americans' buying power.
"Despite all of what we have accomplished up to now, it is not enough," Sanders said Wednesday. "Working together, we can take on the greed of the pharmaceutical industry and substantially lower the cost of prescription drugs in America. And when we do that, we will be lowering the cost of health care in our country."
Kathryn WatsonKathryn Watson is a politics reporter for CBS News Digital based in Washington, D.C.
veryGood! (8955)
Related
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- Fifth suspect charged in Philadelphia bus stop shooting that wounded 8
- Virginia governor vetoes 22 bills, including easier path for certain immigrants to work as police
- NFL will allow Eagles' Tush Push play to remain next season
- Paige Bueckers vs. Hannah Hidalgo highlights women's basketball games to watch
- Megan Thee Stallion to go on Hot Girl Summer Tour with rapper GloRilla: How to get tickets
- Amid migrant crisis, Massachusetts debates how best to keep families housed
- Lawsuit from family of Black man killed by police in Oregon provides additional details of shooting
- The 401(k) millionaires club keeps growing. We'll tell you how to join.
- No. 11 Oregon stays hot and takes out South Carolina in another NCAA Tournament upset
Ranking
- Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
- In Deep Red Utah, Climate Concerns Are Now Motivating Candidates
- Quoting Dr. Seuss, ‘Just go, Go, GO!’ federal judge dismisses Blagojevich political comeback suit
- Beyoncé’s Rep Appears to Respond After Erykah Badu Criticizes Album Cover
- Taylor Swift makes surprise visit to Kansas City children’s hospital
- Grassley releases whistleblower documents, multi-agency probe into American cartel gunrunning
- Trump could score $3.5 billion from Truth Social going public. But tapping the money may be tricky.
- The trial of an Arizona border rancher charged with killing a migrant is set to open
Recommendation
Could your smelly farts help science?
The Best Maternity Swimsuits That Are Comfy, Cute, and Perfect for Postpartum Life
Top 5 most popular dog breeds of 2023 in America: Guess which is No. 1?
Review: ‘Water for Elephants’ on Broadway is a three-ring circus with zero intrigue
SFO's new sensory room helps neurodivergent travelers fight flying jitters
Lack of buses keeps Los Angeles jail inmates from court appearances and contributes to overcrowding
Stock market today: Asian shares are mixed after another Wall Street record day
United Airlines now allows travelers to pool their air miles with others